Krystal Knapp

Biomarkers offer great potential for improving management of cancer at every point from screening and detection, to diagnosis, staging, prognosis, and the assessment of treatment response.

As personalized medicine occupies a growing role in the pharmaceutical pipeline, major companies are changing their research and development paradigms.

The latest cancer study. A book-signing event. A hospital mural project. These topics and more are all fodder for the Fox Chase Cancer Center's Facebook page